F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000
Release Date:
08/31/2017
... expected to transform treatment in the coming years. The new therapy turns a patient’s cells into a “living ... remissions and possibly even cures. The therapy, marketed as Kymriah and made by Novartis, was...